JPRN-UMIN000001121已完成未知
Metabolism of Iron and Erythropoiesis-stimulating agents (ESA) in chronic kidney disease (CKD) - MIE study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Malignancy 2)Malnutrition 3)Active inflammatory or infectious disease 4)Uncontrollable diabetes mellitus 5)Abdominal ascites or pleural effusion 6)Pregnancy 7)Inappropriate for this study judged by the physicians
研究者
相似试验
已完成
不适用
Effect of iron supplementation on erythropoiesis and iron-related parameters in hemodialysis patients receiving epoetin beta pegol: a randomized controlled studyPatients treated with maintenance hemodialysisJPRN-UMIN000010084Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine200
已完成
4 期
Iron Alone or Iron and Erythropoietin Added to Acute Normovolemic Hemodilution in myomectomy patients : A Randomized controlled Trialmyomectomy surgeryuterine fibroidsBlood - AnaemiaAnaesthesiology - Other anaesthesiologyReproductive Health and Childbirth - Other reproductive health and childbirth disordersACTRN12615000152527Hoda Alsaid Ahmed Ezz90
已完成
Unknown
To study whether serum iron metabolism markers including NTBI is related to mortality in HD patients.Hemodialysis patientsJPRN-jRCT1090220403Shigeru miyzaki300
尚未招募
不适用
Serum iron profile in anemiasCTRI/2021/01/030837Rmch bareilly
Unknown
Unknown
The observation of the changes of iron metabolic and oxidative stress markers after intravenous injection in HD patientsHemodialysis patientsJPRN-jRCT1090220139Shigeru Miyazaki20